Linyi, China

Zhiquan Zhao

This inventor holds 8 USPTO granted patents and 4 published patent applications and 10 EPO patents. Top assignees: Lunan Pharmaceutical Group Corporation, Chongqing Fagen Biomedical Inc., Fagen Biomedical Inc. Chongqing. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiquan Zhao. Retrieved from https://idiyas.com/inventor/zhiquan-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 74(Granted Patents)


Location History:

  • Jiulongpo Chongqing, CN (2013)
  • Chongqing, CN (2014)
  • Linyi, CN (2013 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovations in Medicine: The Contributions of Inventor Zhiquan Zhao**

Introduction

Zhiquan Zhao is a prominent inventor based in Linyi, China, known for his significant contributions to the field of medicine. With a total of 8 patents to his name, Zhao has focused particularly on developing innovative solutions for treating hematocytopenia, a condition that can have serious implications for patients undergoing chemotherapy.

Latest Patents

Among his recent innovations, Zhao has worked on the application of icaritin, a natural product derived from various plants, in preparing medicaments aimed at preventing or treating hematocytopenia. His methods highlight the potential of icaritin to provide relief by preventing bone marrow suppression from chemotherapeutic drugs. Additionally, his patents indicate that the use of icaritin may also extend to treating conditions such as thrombocytopenia, including immune thrombocytopenia.

Career Highlights

Zhiquan Zhao has been instrumental in the advancement of medicinal therapies through his innovative research and development efforts. His work at established companies like Lunan Pharmaceutical Group Corporation and Chongqing Fagen Biomedical Inc. has helped pave the way for new treatments, thereby enhancing patient care in oncology.

Collaborations

Throughout his career, Zhao has collaborated with notable colleagues such as Kai Fan and Chun Zhang. These partnerships have allowed for a combined effort in research and development, fostering an environment of shared knowledge and innovation within the biomedical field.

Conclusion

Zhiquan Zhao's work exemplifies dedication to improving healthcare through innovation. His contributions to the treatment of hematocytopenia through the use of icaritin demonstrate the impact that innovative thinkers can have on modern medicine. As he continues to explore new frontiers in pharmacology, Zhao's inventiveness remains a beacon of hope for patients and the medical community alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…